| CJH Stock | | | 3.34 0.02 0.60% |
Founder
Tao Zhu is Ex CoFounder of CanSino Biologics
| Age | 49 |
| Phone | 400 922 2099 |
| Web | https://www.cansinotech.com |
CanSino Biologics Management Efficiency
The company has return on total asset
(ROA) of
(0.0207) % which means that it has lost $0.0207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0111 %, meaning that it generated $0.0111 on every $100 dollars invested by stockholders. CanSino Biologics' management efficiency ratios could be used to measure how well CanSino Biologics manages its routine affairs as well as how well it operates its assets and liabilities.
CanSino Biologics (CJH) is traded on Stuttgart Exchange in Germany and employs 9 people.
Management Performance
CanSino Biologics Leadership Team
Elected by the shareholders, the CanSino Biologics' board of directors comprises two types of representatives: CanSino Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CanSino. The board's role is to monitor CanSino Biologics' management team and ensure that shareholders' interests are well served. CanSino Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CanSino Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yonghui Wu, VP Marketing | |
| Xuefeng Yu, Chairman, CoFounder | |
| Tao Zhu, Ex CoFounder | |
| Chunlin Xin, Director Department | |
| Xi Luo, Chief Officer | |
| FCS FCIS, Joint Sec | |
| Dongxu MBA, Exec CoFounder | |
| Jing Wang, Deputy Officer | |
| ShouBai Chao, COO Director | |
CanSino Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CanSino Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for CanSino Stock Analysis
When running CanSino Biologics' price analysis, check to
measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to
predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.